Rainbow Children’s Medicare has debuted at Rs 506.00 on the BSE, down by 36 points or 6.64% from its issue price of Rs 542.
The scrip is currently trading at Rs 492.30, up by 49.70 points or 9.17% from its issue price. It has touched a high and low of Rs 519.35 and Rs 482.00 respectively. So far 2.25 lakh shares were traded on the counter.
The offering, which was open for subscription between April 27, 2022 and April 29, 2022, was subscribed 12.43 times on the last day of the bidding. The issue price was fixed at Rs 542 per share i.e. at upper end of price band of Rs 516-542 apiece.
Rainbow Children’s Medicare’s core specialties are pediatrics, which includes newborn and pediatric intensive care, pediatric multi-specialty services, pediatric quaternary care (including multi organ transplants); and obstetrics and gynecology, which includes normal and complex obstetric care, multi-disciplinary fetal care, perinatal genetic and fertility care.
| Company Name | CMP |
|---|---|
| Apollo Hospital Ent. | 7699.05 |
| Max Healthcare Inst | 1006.90 |
| Narayana Hrudayalay | 1825.55 |
| Aster DM Healthcare | 688.30 |
| Global Health | 1089.55 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: